Therefore, enhancing skeletal muscle-specific PAK1 signaling could ameliorate muscle metabolic dysfunction, improve insulin sensitivity, reverse prediabetes and prevent progression to T2D. This evidence concerns the gene INS and type 2 diabetes mellitus.